Key Metrics and Growth Forecasts from Medtronic's Q4 2024 Earnings
Thursday, 23 May 2024, 11:04
Key Highlights:
Medtronic plc (NYSE: MDT) reported its Q4 2024 earnings results, showing worldwide revenue growth. Net income saw a significant decline compared to the previous year.
Financial Performance:
- Revenue: $8.6 billion, up 0.5% reported and 5.4% organic
- Net Income: $654 million, down 45%
- EPS: $0.49, a 44% decline
- Adjusted EPS: $1.46, decreased by 7%
The company expects organic revenue growth of 4-5% and adjusted EPS ranging from $5.40-5.50 for fiscal year 2025.
Prior Performance:
Gain insight into the recent financial results of Medtronic to assess its financial health and future prospects.
This article was prepared using information from open sources in accordance with the principles of Ethical Policy. The editorial team is not responsible for absolute accuracy, as it relies on data from the sources referenced.